Relizorb

Relizorb is an FDA 510(k)-cleared medical device (K161247) manufactured by Alcresta Therapeutics, Inc.. This device is classified under the Gastroenterology, Urology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on June 29, 2016. Regulation: 8.